Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Male Infertility Market, by Treatment
1.4.2 Europe Male Infertility Market, by Tests
1.4.3 Europe Male Infertility Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Male Infertility Market by Treatment
3.1 Europe Assisted Reproductive Technology and Varicocele Surgery Market by Country
3.2 Europe Medication Market by Country
Chapter 4. Europe Male Infertility Market by Test
4.1 Europe DNA Fragmentation Technique Market by Country
4.2 Europe Oxidative Stress Analysis Market by Country
4.3 Europe Computer Assisted Semen Analysis Market by Country
4.4 Europe Microscopic Examination Market by Country
4.5 Europe Sperm Agglutination Market by Country
4.6 Europe Sperm Penetration Assay Market by Country
4.7 Europe Other Test Market by Country
Chapter 5. Europe Male Infertility Market by Country
5.1 Germany Male Infertility Market
5.1.1 Germany Male Infertility Market by Treatment
5.1.2 Germany Male Infertility Market by Test
5.2 UK Male Infertility Market
5.2.1 UK Male Infertility Market by Treatment
5.2.2 UK Male Infertility Market by Test
5.3 France Male Infertility Market
5.3.1 France Male Infertility Market by Treatment
5.3.2 France Male Infertility Market by Test
5.4 Russia Male Infertility Market
5.4.1 Russia Male Infertility Market by Treatment
5.4.2 Russia Male Infertility Market by Test
5.5 Spain Male Infertility Market
5.5.1 Spain Male Infertility Market by Treatment
5.5.2 Spain Male Infertility Market by Test
5.6 Italy Male Infertility Market
5.6.1 Italy Male Infertility Market by Treatment
5.6.2 Italy Male Infertility Market by Test
5.7 Rest of Europe Male Infertility Market
5.7.1 Rest of Europe Male Infertility Market by Treatment
5.7.2 Rest of Europe Male Infertility Market by Test
Chapter 6. Company Profiles
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview
Unique Offerings 